Results 31 to 40 of about 4,727 (145)

Pulmonary veno-occlusive disease: Two children with gradual disease progression

open access: yesRespiratory Medicine Case Reports, 2017
Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis are rare forms of pulmonary vascular disease. We report two cases of affected children who had evidence of pulmonary hypertension 3–5 years before developing radiographic findings ...
Ronald W. Day   +6 more
doaj   +1 more source

Idiopathic Pulmonary Veno-Occlusive Disease

open access: yesInternal Medicine, 2009
We report a case of idiopathic pulmonary veno-occlusive disease (PVOD). The patient experienced progressively worsening dyspnea. Heart catheterization revealed severe pulmonary hypertension. High-resolution computed tomography (HRCT) showed diffuse, poorly identified centrilobular ground-glass opacities.
Iwaki, Mai   +5 more
openaire   +3 more sources

Pulmonary vein occlusion and veno-occlusive disease in a bilateral lung transplant patient: A case report

open access: yesRespiratory Medicine Case Reports, 2020
A pulmonary vein occlusion and biopsy proven pulmonary veno-occlusive disease (PVOD) and hemangiomatosis is found in a bilateral lung transplant patient.
Xiao Wang   +3 more
doaj   +1 more source

Unique wreath-like smooth muscle proliferation of the pulmonary vasculature in pulmonary veno-occlusive disease versus pulmonary arterial hypertension

open access: yesJournal of the Formosan Medical Association, 2020
Background/purpose: Pulmonary veno-occlusive disease (PVOD) is a rare but fatal cause of pulmonary hypertension reported to be linked to mutations of eukaryotic initiation factor 2 alpha kinase 4 (EIF2AK4), also known as general control nonderepressible ...
Ying-Ju Lai   +3 more
doaj   +1 more source

Co-existence of vocal cord dysfunction with pulmonary conditions other than asthma: A case series

open access: yesRespiratory Medicine Case Reports, 2018
Background: Vocal cord dysfunction (VCD) is defined as inappropriate movement of the vocal cords resulting in functional airway obstruction and symptoms including cough, wheezing, and dyspnea.
Merritt L. Fajt   +3 more
doaj   +1 more source

Pulmonary Veno-Occlusive Disease: A Rare Cause of Pulmonary Hypertension

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2019
Pulmonary veno-occlusive disease (PVOD) is a rare entity that is usually mistaken with pulmonary arterial hypertension (PAH) but is considered class I′ of PAH. It is important to subclassify PVOD and distinguish it from PAH as treatment with vasodilators
Said Hajouli MD   +2 more
doaj   +1 more source

Post‐Market Analysis of the Xenios Console With the Xlung Tubing Kit 230 for Extracorporeal Membrane Oxygenation After Cardiac Surgery

open access: yesArtificial Organs, EarlyView.
This study is a comprehensive post‐market analysis of the Xenios console and XLung kit 230 preconfigured ECMO tubing set in post‐cardiotomy applications. The performance of this device was evaluated and demonstrated in all key clinical areas, with an adequate safety profile.
Luca Conci   +9 more
wiley   +1 more source

Clinical features of canine pulmonary veno‐occlusive disease and pulmonary capillary hemangiomatosis

open access: yesJournal of Veterinary Internal Medicine, 2019
Background Histologic features of pulmonary veno‐occlusive disease (PVOD) and pulmonary capillary hemangiomatosis (PCH) have been described in dogs but without a thorough clinical description.
Carol R. Reinero   +5 more
doaj   +1 more source

Pulmonary hypertension phenotypes in patients with systemic sclerosis

open access: yesEuropean Respiratory Review, 2021
Pulmonary hypertension (PH) commonly affects patients with systemic sclerosis (SSc) and is associated with significant morbidity and increased mortality.
Ashraful Haque   +4 more
doaj   +1 more source

Red lines and green lights: Gene therapy for inherited erythroid disorders beyond the haemoglobinopathies

open access: yesBritish Journal of Haematology, EarlyView.
Gene therapy is revolutionizing treatment paradigms for haemoglobinopathies, establishing a translational framework for disorders that impact red blood cell development. In their paper, Joshi et al. describe the preclinical and early clinical landscape of gene therapies for non‐haemoglobinopathy erythroid disorders and highlight common thematic ...
Gaurav Joshi   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy